Pune, Maharashtra -- (SBWIRE) -- 05/02/2017 -- Market Synopsis of Anti-Hypertensive Drugs:
Market Overview and Scenario:
Anti-Hypertensive Drugs are used for the treatment of high blood pressure arising due to several factors. The Anti-Hypertensive Drug Market is characterised by low rate of return on most drugs due to greater penetration of generics due to loss of patents of major blockbusters. Thus the strategy of most companies revolve around same for less or more for more. Availability of a number of effective substitute and fragmentation of market along with good efficacy and cost effectiveness of traditional anti-hypertensive drugs act as a drag on charging a premium. This also reduces any propensity of volatility in the future market unless the development of drug having a special property such as additional benefit for patients suffering from other diseases. Thus a premium can be charged on special anti-hypertensive drugs such as /angiotensin II receptor blockers (ARBs) and ACE inhibitors which prolong survival in patients with congestive heart failure and diabetes mellitus. Thus combination therapy will be on the rise. The uptake of any newer drug will be slow in face of competition and apprehensions about its safety, efficacy and special benefit potential. Thus marketing cost will tend to be higher further reducing profits.
Market Research Future published a half-cooked research report on Anti-Hypertensive Drug Market. The Global Anti-Hypertensive Drug Market is expected to grow at a CAGR of ~2.73 % during the period 2016 to 2022.
Anti-Hypertensive Drug Market - Key Players:
The major participants of this market are: Novartis AG, Daiichi Sankyo Company Ltd., Astra Zeneca plc, Sanofi S.A., Pfizer Inc., Acetelion Ltd, Merck & Co., Boehringer Ingelheim, Lupin Ltd., Johnson & Johnson Ltd., Ranbaxy Laboratories Ltd., Inc., Takeda Pharmaceutical, Bayer AG etc.
Receive a Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/2347
Depending on geographic region, Anti-Hypertensive Drug Market is segmented into four key regions: Americas, Europe, Asia Pacific, and Middle East & Africa. Globally developed countries led by North America is the largest market for Anti-hypertensive drugs. Europe is the second-largest market for anti-hypertensive drugs. The developed region will lose the lead to the developing in the nearest future. Anti-hypertensive drugs will be one of the greatest beneficiaries of the disease shift from developed to developing regions. But there seems to be no greater benefit except greater sales to the companies.
Global Anti-Hypertensive Drugs Market has been segmented on the basis of pharmacological class which comprises diuretics, ace inhibitors, calcium channel blockers, adrenergic blockers, central sympatholytic, renin inhibitors and vasodilators. On the basis of application; market is segmented into primary or essential hypertension and secondary hypertension. On the basis of hypertension type into systemic hypertension drugs and pulmonary hypertension drugs
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028